1. First-line Immune Checkpoint Inhibitor Versus Immune Checkpoint Inhibitor With Chemotherapy for Cisplatin-ineligible Metastatic Urothelial Carcinoma: Evidence From a Real-world, Multicenter Analysis. Issue 9 (20th November 2022) Authors: Lin, Chang-Ting; Su, Po-Jung; Huang, Shih-Yu; Wu, Chia-Che; Wang, Hung-Jen; Cheng, Yuan-Tso; Luo, Hao-Lun; Chen, Chien-Hsu; Liu, Ting-Ting; Huang, Chun-Chieh; Su, Yu-Li Journal: Journal of immunotherapy Issue: Volume 45:Issue 9(2022) Page Start: 407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗